Literature DB >> 27781029

Novel KCNQ3 Mutation in a Large Family with Benign Familial Neonatal Epilepsy: A Rare Cause of Neonatal Seizures.

Snezana Maljevic1, Sabina Vejzovic2, Matthias K Bernhard3, Astrid Bertsche3, Sebastian Weise3, Miriam Döcker4, Holger Lerche2, Johannes R Lemke5, Andreas Merkenschlager3, Steffen Syrbe6.   

Abstract

Benign familial neonatal seizures (BFNS) present a rare familial epilepsy syndrome caused by genetic alterations in the voltage-gated potassium channels Kv7.2 and Kv7.3, encoded by KCNQ2 and KCNQ3. While most BFNS families carry alterations in KCNQ2, mutations in KCNQ3 appear to be less common. Here, we describe a family with 6 individuals presenting with neonatal focal and generalized seizures. Genetic testing revealed a novel KCNQ3 variant, c.835G>T, cosegregating with seizures in 4 tested individuals. This variant results in a substitution of the highly conserved amino acid valine localized within the pore-forming transmembrane segment S5 (p.V279F). Functional investigations in Xenopus laevis oocytes revealed a loss of function, which supports p.V279F as a pathogenic mutation. When p.V279F was coexpressed with the wild-type (WT) Kv7.2 subunits, the resulting potassium currents were about 10-fold reduced compared to the WT Kv7.3 and Kv7.2 coexpression. Genotype-phenotype correlation shows an incomplete penetrance of p.V279F. Response to antiepileptic treatment was variable, but evaluation of treatment response remained challenging due to the self-limiting character of the disease. The identification of the pathogenic variant helped to avoid unnecessary investigations in affected family members and allowed guided therapy.

Entities:  

Keywords:  Familial neonatal convulsions; KCNQ2; KCNQ3; Levetiracetam; Neonatal seizures; Potassium channels

Year:  2016        PMID: 27781029      PMCID: PMC5073621          DOI: 10.1159/000447461

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  18 in total

1.  A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family.

Authors:  C Charlier; N A Singh; S G Ryan; T B Lewis; B E Reus; R J Leach; M Leppert
Journal:  Nat Genet       Date:  1998-01       Impact factor: 38.330

2.  KCNQ2 and KCNQ3 mutations contribute to different idiopathic epilepsy syndromes.

Authors:  B A Neubauer; S Waldegger; J Heinzinger; A Hahn; G Kurlemann; B Fiedler; F Eberhard; H Muhle; U Stephani; S Garkisch; O Eeg-Olofsson; U Müller; T Sander
Journal:  Neurology       Date:  2008-07-15       Impact factor: 9.910

3.  Altered KCNQ3 potassium channel function caused by the W309R pore-helix mutation found in human epilepsy.

Authors:  Akira Uehara; Yuki Nakamura; Takao Shioya; Shinichi Hirose; Midori Yasukochi; Kiyoko Uehara
Journal:  J Membr Biol       Date:  2008-04-20       Impact factor: 1.843

4.  Mouse models of human KCNQ2 and KCNQ3 mutations for benign familial neonatal convulsions show seizures and neuronal plasticity without synaptic reorganization.

Authors:  Nanda A Singh; James F Otto; E Jill Dahle; Chris Pappas; Jonathan D Leslie; Alex Vilaythong; Jeffrey L Noebels; H Steve White; Karen S Wilcox; Mark F Leppert
Journal:  J Physiol       Date:  2008-05-15       Impact factor: 5.182

5.  Genetic testing in benign familial epilepsies of the first year of life: clinical and diagnostic significance.

Authors:  Federico Zara; Nicola Specchio; Pasquale Striano; Angela Robbiano; Elena Gennaro; Roberta Paravidino; Nicola Vanni; Francesca Beccaria; Giuseppe Capovilla; Amedeo Bianchi; Lorella Caffi; Viviana Cardilli; Francesca Darra; Bernardo Dalla Bernardina; Lucia Fusco; Roberto Gaggero; Lucio Giordano; Renzo Guerrini; Gemma Incorpora; Massimo Mastrangelo; Luigina Spaccini; Anna Maria Laverda; Marilena Vecchi; Francesca Vanadia; Pierangelo Veggiotti; Maurizio Viri; Guya Occhi; Mauro Budetta; Maurizio Taglialatela; Domenico A Coviello; Federico Vigevano; Carlo Minetti
Journal:  Epilepsia       Date:  2013-01-29       Impact factor: 5.864

6.  KCNQ2 and KCNQ3 potassium channel genes in benign familial neonatal convulsions: expansion of the functional and mutation spectrum.

Authors:  Nanda A Singh; Peter Westenskow; Carole Charlier; Chris Pappas; Jonathan Leslie; Jessica Dillon; V Elving Anderson; Michael C Sanguinetti; Mark F Leppert
Journal:  Brain       Date:  2003-10-08       Impact factor: 13.501

7.  Early-onset epileptic encephalopathy caused by gain-of-function mutations in the voltage sensor of Kv7.2 and Kv7.3 potassium channel subunits.

Authors:  Francesco Miceli; Maria Virginia Soldovieri; Paolo Ambrosino; Michela De Maria; Michele Migliore; Rosanna Migliore; Maurizio Taglialatela
Journal:  J Neurosci       Date:  2015-03-04       Impact factor: 6.167

8.  A novel KCNQ3 mutation in familial epilepsy with focal seizures and intellectual disability.

Authors:  Francesco Miceli; Pasquale Striano; Maria Virginia Soldovieri; Antonina Fontana; Rosaria Nardello; Angela Robbiano; Giulia Bellini; Maurizio Elia; Federico Zara; Maurizio Taglialatela; Salvatore Mangano
Journal:  Epilepsia       Date:  2014-12-19       Impact factor: 5.864

9.  Novel KCNQ2 and KCNQ3 mutations in a large cohort of families with benign neonatal epilepsy: first evidence for an altered channel regulation by syntaxin-1A.

Authors:  Maria Virginia Soldovieri; Nadia Boutry-Kryza; Mathieu Milh; Diane Doummar; Benedicte Heron; Emilie Bourel; Paolo Ambrosino; Francesco Miceli; Michela De Maria; Nathalie Dorison; Stephane Auvin; Bernard Echenne; Julie Oertel; Audrey Riquet; Laetitia Lambert; Marion Gerard; Anne Roubergue; Alain Calender; Cyril Mignot; Maurizio Taglialatela; Gaetan Lesca
Journal:  Hum Mutat       Date:  2014-01-13       Impact factor: 4.878

10.  Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients.

Authors:  Sarah Weckhuysen; Vanja Ivanovic; Rik Hendrickx; Rudy Van Coster; Helle Hjalgrim; Rikke S Møller; Sabine Grønborg; An-Sofie Schoonjans; Berten Ceulemans; Sinead B Heavin; Christin Eltze; Rita Horvath; Gianluca Casara; Tiziana Pisano; Lucio Giordano; Kevin Rostasy; Edda Haberlandt; Beate Albrecht; Andrea Bevot; Ira Benkel; Steffan Syrbe; Beth Sheidley; Renzo Guerrini; Annapurna Poduri; Johannes R Lemke; Simone Mandelstam; Ingrid Scheffer; Marco Angriman; Pasquale Striano; Carla Marini; Arvid Suls; Peter De Jonghe
Journal:  Neurology       Date:  2013-10-09       Impact factor: 9.910

View more
  4 in total

1.  Large-Scale Exome Sequencing Study Implicates Both Developmental and Functional Changes in the Neurobiology of Autism.

Authors:  F Kyle Satterstrom; Jack A Kosmicki; Jiebiao Wang; Michael S Breen; Silvia De Rubeis; Joon-Yong An; Minshi Peng; Ryan Collins; Jakob Grove; Lambertus Klei; Christine Stevens; Jennifer Reichert; Maureen S Mulhern; Mykyta Artomov; Sherif Gerges; Brooke Sheppard; Xinyi Xu; Aparna Bhaduri; Utku Norman; Harrison Brand; Grace Schwartz; Rachel Nguyen; Elizabeth E Guerrero; Caroline Dias; Catalina Betancur; Edwin H Cook; Louise Gallagher; Michael Gill; James S Sutcliffe; Audrey Thurm; Michael E Zwick; Anders D Børglum; Matthew W State; A Ercument Cicek; Michael E Talkowski; David J Cutler; Bernie Devlin; Stephan J Sanders; Kathryn Roeder; Mark J Daly; Joseph D Buxbaum
Journal:  Cell       Date:  2020-01-23       Impact factor: 41.582

Review 2.  Treating the symptom or treating the disease in neonatal seizures: a systematic review of the literature.

Authors:  Raffaele Falsaperla; Bruna Scalia; Andrea Giugno; Piero Pavone; Milena Motta; Martina Caccamo; Martino Ruggieri
Journal:  Ital J Pediatr       Date:  2021-04-07       Impact factor: 2.638

Review 3.  Aquatic Freshwater Vertebrate Models of Epilepsy Pathology: Past Discoveries and Future Directions for Therapeutic Discovery.

Authors:  Rachel E Williams; Karen Mruk
Journal:  Int J Mol Sci       Date:  2022-08-03       Impact factor: 6.208

Review 4.  Benign and severe early-life seizures: a round in the first year of life.

Authors:  Piero Pavone; Giovanni Corsello; Martino Ruggieri; Silvia Marino; Simona Marino; Raffaele Falsaperla
Journal:  Ital J Pediatr       Date:  2018-05-15       Impact factor: 2.638

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.